Pacific Biosciences Of California Gross Margin 2010-2024 | PACB
Current and historical gross margin for Pacific Biosciences Of California (PACB) over the last 10 years. The current gross profit margin for Pacific Biosciences Of California as of December 31, 2024 is %.
| Pacific Biosciences Of California Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2024-12-31 | $0.15B | $0.04B | 24.03% |
| 2024-09-30 | $0.17B | $0.04B | 21.39% |
| 2024-06-30 | $0.19B | $0.05B | 23.81% |
| 2024-03-31 | $0.20B | $0.06B | 27.36% |
| 2023-12-31 | $0.20B | $0.05B | 26.87% |
| 2023-09-30 | $0.17B | $0.05B | 28.82% |
| 2023-06-30 | $0.15B | $0.05B | 30.82% |
| 2023-03-31 | $0.13B | $0.05B | 33.83% |
| 2022-12-31 | $0.13B | $0.05B | 38.58% |
| 2022-09-30 | $0.14B | $0.06B | 44.85% |
| 2022-06-30 | $0.14B | $0.06B | 44.60% |
| 2022-03-31 | $0.14B | $0.06B | 44.44% |
| 2021-12-31 | $0.13B | $0.06B | 45.04% |
| 2021-09-30 | $0.12B | $0.05B | 43.44% |
| 2021-06-30 | $0.11B | $0.05B | 42.45% |
| 2021-03-31 | $0.09B | $0.04B | 41.30% |
| 2020-12-31 | $0.08B | $0.03B | 40.51% |
| 2020-09-30 | $0.08B | $0.03B | 42.50% |
| 2020-06-30 | $0.08B | $0.03B | 40.96% |
| 2020-03-31 | $0.09B | $0.04B | 40.66% |
| 2019-12-31 | $0.09B | $0.04B | 38.46% |
| 2019-09-30 | $0.08B | $0.03B | 33.73% |
| 2019-06-30 | $0.08B | $0.02B | 30.38% |
| 2019-03-31 | $0.08B | $0.02B | 30.26% |
| 2018-12-31 | $0.08B | $0.03B | 31.65% |
| 2018-09-30 | $0.08B | $0.03B | 33.33% |
| 2018-06-30 | $0.09B | $0.03B | 36.67% |
| 2018-03-31 | $0.09B | $0.03B | 36.36% |
| 2017-12-31 | $0.09B | $0.03B | 36.17% |
| 2017-09-30 | $0.10B | $0.04B | 37.89% |
| 2017-06-30 | $0.10B | $0.04B | 42.71% |
| 2017-03-31 | $0.10B | $0.04B | 45.36% |
| 2016-12-31 | $0.09B | $0.05B | 49.45% |
| 2016-09-30 | $0.10B | $0.06B | 59.41% |
| 2016-06-30 | $0.09B | $0.05B | 60.00% |
| 2016-03-31 | $0.09B | $0.06B | 61.70% |
| 2015-12-31 | $0.09B | $0.05B | 58.06% |
| 2015-09-30 | $0.07B | $0.03B | 43.24% |
| 2015-06-30 | $0.08B | $0.04B | 46.91% |
| 2015-03-31 | $0.07B | $0.03B | 38.81% |
| 2014-12-31 | $0.06B | $0.02B | 37.70% |
| 2014-09-30 | $0.05B | $0.02B | 41.51% |
| 2014-06-30 | $0.04B | $0.01B | 25.64% |
| 2014-03-31 | $0.03B | $0.01B | 23.53% |
| 2013-12-31 | $0.03B | $0.01B | 21.43% |
| 2013-09-30 | $0.03B | $0.00B | 16.00% |
| 2013-06-30 | $0.02B | $0.00B | 14.29% |
| 2013-03-31 | $0.02B | $0.00B | 9.09% |
| 2012-12-31 | $0.03B | $0.00B | 3.85% |
| 2012-09-30 | $0.03B | $0.00B | 6.25% |
| 2012-06-30 | $0.04B | $0.01B | 12.50% |
| 2012-03-31 | $0.04B | $0.01B | 29.55% |
| 2011-12-31 | $0.03B | $0.01B | 38.24% |
| 2011-09-30 | $0.02B | $0.01B | 50.00% |
| 2011-06-30 | $0.01B | $0.01B | 72.73% |
| 2011-03-31 | $0.00B | $0.00B | 100.00% |
| 2010-12-31 | $0.00B | $0.00B | 100.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.348B | $0.154B |
| Pacific Biosciences of California Inc., popularly known as PacBio, develops, manufactures and markets sequencing systems, which help in studying synthesis, composition, structure and regulation of deoxyribonucleic acid, popularly known as DNA. PacBio's products are based on Single Molecule, Real-Time (SMRT) technology. SMRT generates long reads that help in assembling a whole human genome from scratch, without using an existing reference genome as a template. This process is known as de novo assembly. To observe DNA replication process smoothly, PacBio offers the SMRT Cell, Phospholinked nucleotides and The PacBio RS II System. The PacBio RS II System includes the PacBio RS II instrument, consumables and software. PacBio launched its new Sequel system based on SMRT technology. PacBio deferred the gain from the Reverse Termination Fee from Illumina until the date when the associated contingency was resolved. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $171.942B | 78.88 |
| Thermo Fisher Scientific (TMO) | United States | $161.378B | 19.56 |
| Alcon (ALC) | Switzerland | $45.645B | 30.34 |
| Edwards Lifesciences (EW) | United States | $42.050B | 27.30 |
| IDEXX Laboratories (IDXX) | United States | $33.347B | 38.56 |
| DexCom (DXCM) | United States | $26.887B | 41.56 |
| IQVIA Holdings (IQV) | United States | $25.374B | 14.04 |
| STERIS (STE) | Ireland | $21.834B | 24.97 |
| Mettler-Toledo (MTD) | United States | $20.944B | 24.42 |
| Waters (WAT) | United States | $19.099B | 27.04 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.304B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.878B | 14.16 |
| Hologic (HOLX) | United States | $12.916B | 13.94 |
| Sysmex ADR (SSMXY) | Japan | $11.847B | 0.00 |
| Penumbra (PEN) | United States | $10.729B | 96.64 |
| Globus Medical (GMED) | United States | $9.767B | 22.61 |
| Masimo (MASI) | United States | $8.221B | 34.50 |
| Teleflex (TFX) | United States | $6.004B | 9.24 |
| Glaukos (GKOS) | United States | $5.153B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.081B | 22.07 |
| TransMedics (TMDX) | United States | $2.985B | 87.37 |
| PROCEPT BioRobotics (PRCT) | United States | $2.907B | 0.00 |
| Veracyte (VCYT) | United States | $2.427B | 43.86 |
| Nihon Kohden (NHNKY) | Japan | $2.081B | 11.37 |
| LivaNova (LIVN) | United Kingdom | $1.934B | 11.74 |
| Elekta AB (EKTAY) | Sweden | $1.891B | 17.00 |
| Alphatec Holdings (ATEC) | United States | $1.522B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.222B | 6.18 |
| Pulse Biosciences (PLSE) | United States | $1.193B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.122B | 0.00 |
| Paragon 28 (FNA) | United States | $1.099B | 0.00 |
| Artivion (AORT) | United States | $0.979B | 91.72 |
| OPKO Health (OPK) | United States | $0.954B | 0.00 |
| AxoGen (AXGN) | United States | $0.690B | 0.00 |
| IRadimed (IRMD) | United States | $0.658B | 34.51 |
| Mesa Laboratories (MLAB) | United States | $0.609B | 13.30 |
| SiBone (SIBN) | United States | $0.588B | 0.00 |
| RxSight (RXST) | United States | $0.584B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.572B | 9.21 |
| OrthoPediatrics (KIDS) | United States | $0.510B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.508B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.483B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.406B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.389B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.387B | 0.00 |
| NeuroPace (NPCE) | United States | $0.351B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.342B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.315B | 16.87 |
| Semler Scientific (SMLR) | United States | $0.312B | 6.62 |
| Neuronetics (STIM) | United States | $0.247B | 0.00 |
| Inogen (INGN) | United States | $0.183B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.181B | 0.00 |
| 908 Devices (MASS) | United States | $0.168B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.165B | 0.00 |
| LENSAR (LNSR) | United States | $0.164B | 0.00 |
| CVRx (CVRX) | United States | $0.163B | 0.00 |
| Accuray (ARAY) | United States | $0.152B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.137B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.110B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.104B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.104B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.104B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.095B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.087B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.080B | 0.00 |
| InspireMD (NSPR) | Israel | $0.079B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.076B | 11.48 |
| Hyperfine (HYPR) | United States | $0.054B | 0.00 |
| Positron (POSC) | United States | $0.051B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.051B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.043B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.037B | 0.00 | |
| Vicarious Surgical (RBOT) | United States | $0.032B | 0.00 |
| Spectral AI (MDAI) | United States | $0.031B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Precision Optics (POCI) | United States | $0.030B | 0.00 |
| Envoy Medical (COCH) | United States | $0.029B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.027B | 0.00 |
| NexGel (NXGL) | United States | $0.022B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.014B | 0.00 |
| PAVmed (PAVM) | United States | $0.012B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.012B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.010B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.007B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.006B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |